These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 18572072)

  • 21. The predictive role of blood glucose for mortality in subjects with cardiovascular disease.
    Port SC; Boyle NG; Hsueh WA; Quiñones MJ; Jennrich RI; Goodarzi MO
    Am J Epidemiol; 2006 Feb; 163(4):342-51. PubMed ID: 16373527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Useful and useless tests for diabetes diagnosis and care].
    Passa P
    Rev Prat; 2003 May; 53(10):1069-73. PubMed ID: 12846026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Level of serum IL-12 and its correlation with endothelial dysfunction, insulin resistance, proinflammatory cytokines and lipid profile in newly diagnosed type 2 diabetes.
    Mishra M; Kumar H; Bajpai S; Singh RK; Tripathi K
    Diabetes Res Clin Pract; 2011 Nov; 94(2):255-61. PubMed ID: 21855158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subclinical diabetes mellitus: is it really "sub-clinical"?
    Keebler ME; McGuire DK
    Am Heart J; 2003 Aug; 146(2):210-2. PubMed ID: 12891185
    [No Abstract]   [Full Text] [Related]  

  • 25. Modified lipoproteins as biomarkers of cardiovascular risk in diabetes mellitus.
    Sánchez-Quesada JL; Pérez A
    Endocrinol Nutr; 2013 Nov; 60(9):518-28. PubMed ID: 23545115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of cardiovascular events after liver transplantation: a role for pretransplant serum troponin levels.
    Coss E; Watt KD; Pedersen R; Dierkhising R; Heimbach JK; Charlton MR
    Liver Transpl; 2011 Jan; 17(1):23-31. PubMed ID: 21254341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The burden of hyperlipidaemia and diabetes in cardiovascular diseases.
    Merkler M; Reiner Z
    Fundam Clin Pharmacol; 2007 Nov; 21 Suppl 2():1-3. PubMed ID: 18001311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular risk assessment in prediabetes: A hypothesis.
    Nwose EU; Richards RS; Cann NG; Butkowski E
    Med Hypotheses; 2009 Mar; 72(3):271-5. PubMed ID: 19042094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating soluble RAGE as a predictive biomarker of cardiovascular event risk in patients with type 2 diabetes.
    Fujisawa K; Katakami N; Kaneto H; Naka T; Takahara M; Sakamoto F; Irie Y; Miyashita K; Kubo F; Yasuda T; Matsuoka TA; Shimomura I
    Atherosclerosis; 2013 Apr; 227(2):425-8. PubMed ID: 23384720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. More insights on the dysglycaemia-cardiovascular connection.
    Gerstein HC
    Lancet; 2010 Jun; 375(9733):2195-6. PubMed ID: 20609955
    [No Abstract]   [Full Text] [Related]  

  • 31. Contemporary model for cardiovascular risk prediction in people with type 2 diabetes.
    Kengne AP; Patel A; Marre M; Travert F; Lievre M; Zoungas S; Chalmers J; Colagiuri S; Grobbee DE; Hamet P; Heller S; Neal B; Woodward M;
    Eur J Cardiovasc Prev Rehabil; 2011 Jun; 18(3):393-8. PubMed ID: 21450612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Postprandial hyperglycemia. Postprandial blood glucose fluctuations, cardiovascular disease and late diabetic complications].
    Madsbad S; Brock B; Schmitz O
    Ugeskr Laeger; 2003 Aug; 165(33):3149-53. PubMed ID: 12968409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Laboratory-based versus non-laboratory-based CVD risk analysis.
    Niederseer D; Niebauer J
    Lancet; 2008 Jun; 371(9630):2081; author reply 2082-3. PubMed ID: 18572070
    [No Abstract]   [Full Text] [Related]  

  • 34. Gestational diabetes mellitus: taking it to heart.
    Marcinkevage JA; Narayan KM
    Prim Care Diabetes; 2011 Jul; 5(2):81-8. PubMed ID: 21106447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive accuracy of the 'Framingham's general CVD algorithm' in a Middle Eastern population: Tehran Lipid and Glucose Study.
    Bozorgmanesh M; Hadaegh F; Azizi F
    Int J Clin Pract; 2011 Mar; 65(3):264-73. PubMed ID: 21314863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Laboratory and non-laboratory-based risk prediction models for secondary prevention of cardiovascular disease: the LIPID study.
    Cui J; Forbes A; Kirby A; Simes J; Tonkin A
    Eur J Cardiovasc Prev Rehabil; 2009 Dec; 16(6):660-8. PubMed ID: 19738473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are traditional risk factors valid for assessing cardiovascular risk in end-stage renal failure patients?
    Shah DS; Polkinghorne KR; Pellicano R; Kerr PG
    Nephrology (Carlton); 2008 Dec; 13(8):667-71. PubMed ID: 18761627
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Natriuretic peptide--independent marker of cardiovascular diseases in patients with diabetes mellitus].
    Zueva NA; Efimov AS
    Lik Sprava; 2006; (3):25-8. PubMed ID: 17100179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between a low ankle brachial index and all-cause death and cardiovascular events in subjects with and without diabetes.
    Yokoyama H; Sone H; Honjo J; Okizaki S; Yamada D; Shudo R; Shimizu H; Moriya T; Haneda M
    J Atheroscler Thromb; 2014; 21(6):574-81. PubMed ID: 24492523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular disease: application of a composite risk index from the Telehealth System in a district community.
    Yip YB; Wong TK; Chung JW; Ko SK; Sit JW; Chan TM
    Public Health Nurs; 2004; 21(6):524-32. PubMed ID: 15566557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.